• Publications
  • Influence
Cancer of the gastric stump following distal gastrectomy for cancer
Cancer of the gastric stump (CGS) after distal gastrectomy for cancer has not been characterized in a large study. The aim of this study was to investigate the clinicopathological features andExpand
  • 93
  • 9
Neuroendocrine Carcinoma of the Stomach: Morphologic and Immunohistochemical Characteristics and Prognosis
Neuroendocrine carcinoma (NEC) of the stomach has been recognized as a highly malignant tumor; however, because of its rarity, limited information is available regarding its clinicopathologicExpand
  • 67
  • 9
Identification of Risk Factors for Esophagojejunal Anastomotic Leakage after Gastric Surgery
BackgroundDespite the development of the surgical technique and improvements in perioperative management, anastomotic leakage still occurs at esophagojejunal anastomoses after total or proximalExpand
  • 57
  • 5
Tumor initiating potential of side population cells in human gastric cancer.
Side population (SP) cells are a small subpopulation of cells with enriched source of gastric tumor-initiating cells (TICs) with stem-like cell property that are characterized by high efflux abilityExpand
  • 120
  • 2
  • PDF
Surgical treatment of non‐early gastric remnant carcinoma developing after distal gastrectomy for gastric cancer
The optimal surgical procedure for gastric remnant carcinoma (GRC) remains debatable. The aim of this study was to retrospectively evaluate the surgical treatments for T2‐4 GRC developing afterExpand
  • 20
  • 2
Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo
BACKGROUND/AIMS Gastric cancer is one of the most prevalent forms of cancer in East Asia. Point mutation of the p53 gene has been reported in more than 60% of cases of gastric cancer and can lead toExpand
  • 41
  • 1
Adenovirus-mediated interferon α gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer
We previously demonstrated a characteristically high sensitivity of pancreatic cancer cells to interferon alpha (IFN-α) gene transfer, which induced a more prominent growth suppression and cell deathExpand
  • 36
  • 1
Local interferon‐α gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster
The interferon (IFN) protein is a cytokine with pleiotropic biological functions that include induction of apoptosis, inhibition of angiogenesis and immunomodulation. We previously examined the twoExpand
  • 26
  • 1
Allogeneic MHC Gene Transfer Enhances an Effective Antitumor Immunity in the Early Period of Autologous Hematopoietic Stem Cell Transplantation
Purpose: In autologous hematopoietic stem cell transplantation (HSCT), lymphopenia-induced homeostatic proliferation of T cells is driven by the recognition of self-antigens, and there is anExpand
  • 17
  • 1
Intratumoral interferon-α gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation
One of the major challenges in the treatment of solid cancers by allogenic hematopoietic stem cell transfer (alloHSCT) is the specific enhancement of antitumor immunity. Interferon (IFN) is aExpand
  • 10
  • 1